Search Count: 19
![]() |
Crystal Structure Of Dck C4S-S74E Mutant In Complex With Edc And Udp
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2023-12-20 Classification: TRANSFERASE Ligands: UDP, VVC |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-12-20
Ligands: UDP, VVC
![]() |
Human Plasmakallikrein Protease Domain In Complex With Active Site Directed Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: GSH, DMS, PO4, GOL, MU8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: GSH, DMS, PO4, GOL, MU8
![]() |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.17 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: SO4, DMS, NA, J7B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: SO4, DMS, NA, J7B
![]() |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: NW2, SO4, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: NW2, SO4, DMS
![]() |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: SO4, DMS, NW5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: SO4, DMS, NW5
![]() |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: NWE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: NWE
![]() |
Coagulation Factor Xi Catalytic Domain (C123S) In Complex With Nvp-Xiv936
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.26 Å Release Date: 2020-07-01 Classification: HYDROLASE Ligands: QGS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-01
Ligands: QGS
![]() |
Aav8 Human Hek293-Produced, Full Capsid
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY Release Date: 2020-06-03 Classification: VIRUS |
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY
Release Date: 2020-06-03
![]() |
Aav8 Human Hek293-Produced, Empty Capsid
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY Release Date: 2020-06-03 Classification: VIRUS |
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY
Release Date: 2020-06-03
![]() |
Aav8 Baculovirus-Sf9 Produced, Full Capsid
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY Release Date: 2020-06-03 Classification: VIRUS |
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY
Release Date: 2020-06-03
![]() |
Aav8 Baculovirus-Sf9 Produced, Empty Capsid
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY Release Date: 2020-06-03 Classification: VIRUS |
Organism: Adeno-associated virus - 8
Method: ELECTRON MICROSCOPY
Release Date: 2020-06-03
![]() |
Complement Factor B In Complex With 5-Bromo-3-Chloro-N-(4,5-Dihydro-1H-Imidazol-2-Yl)-7-Methyl-1H-Indol-4-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.84 Å Release Date: 2020-03-04 Classification: HYDROLASE Ligands: MVZ, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: MVZ, SO4
![]() |
Complement Factor B In Complex With (S)-5,7-Dimethyl-4-((2-Phenylpiperidin-1-Yl)Methyl)-1H-Indole
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2020-03-04 Classification: HYDROLASE Ligands: SO4, MVK, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: SO4, MVK, ZN
![]() |
Complement Factor B In Complex With (-)-4-(1-((5,7-Dimethyl-1H-Indol-4-Yl)Methyl)Piperidin-2-Yl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2020-03-04 Classification: HYDROLASE Ligands: SO4, MVW, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: SO4, MVW, ZN
![]() |
Crystal Structure Of Human Nampt In Complex With Nvp-Ltm976
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2019-12-04 Classification: TRANSFERASE Ligands: OE4, PO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-12-04
Ligands: OE4, PO4
![]() |
Complement Factor B Protease Domain In Complex With The Reversible Inhibitor 4-((2S,4S)-4-Ethoxy-1-((5-Methoxy-7-Methyl-1H-Indol-4-Yl)Methyl)Piperidin-2-Yl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-04-17 Classification: HYDROLASE Ligands: SO4, JGQ, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-04-17
Ligands: SO4, JGQ, ZN
![]() |
Complement Factor B Protease Domain In Complex With The Reversible Inhibitor N-(2-Bromo-4-Methylnaphthalen-1-Yl)-4,5-Dihydro-1H-Imidazol-2-Amine.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2019-03-27 Classification: HYDROLASE Ligands: SO4, JGT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-03-27
Ligands: SO4, JGT
![]() |
Complement Factor B Protease Domain In Complex With The Reversible Inhibitor ((2S,4S)-1-((5,7-Dimethyl-1H-Indol-4-Yl)Methyl)-4-Methoxypiperidin-2-Yl)Methanol.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2019-03-27 Classification: HYDROLASE Ligands: SO4, JGN, ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-03-27
Ligands: SO4, JGN, ZN
![]() |
Structure Of The Clostridium Perfringens Cspb Protease
Organism: Clostridium perfringens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2013-04-03 Classification: HYDROLASE Ligands: CL, NA, EDO |
Organism: Clostridium perfringens
Method: X-RAY DIFFRACTION
Release Date: 2013-04-03
Ligands: CL, NA, EDO
